Jamison Robert N, Dorado Kathleen, Mei Anna, Edwards Robert R, Martel Marc O
Pain Management Center, Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Faculties of Dentistry and Medicine, McGill University, Montreal, Canada.
Pain Rep. 2017 Mar 6;2(2):e589. doi: 10.1097/PR9.0000000000000589. eCollection 2017 Mar.
There is increasing concern among primary care practitioners about the use of opioids for chronic pain, including their adverse effects, but little attention has been given to how reports of side effects from prescription medication can contribute to outcomes among patients with chronic pain. The aim of this study was to investigate the impact of frequently reported side effects on mood, disability, and opioid misuse in patients with chronic pain prescribed opioids within primary care.
Two hundred (N = 200) patients with chronic pain taking opioids for pain were recruited into the study. All patients completed baseline measures and a monthly side effects checklist once a month for 6 months. Patients were divided evenly based on a median split of the number of endorsed side effects over 6 months. The subjects repeated the baseline measures at the end of the study period.
Over time, reports of medication side effects tended to decrease, but differences in frequency of reported side effects from baseline to follow-up (6-month time) were not significant, and the order of the frequency of the reported side effects remained similar. Patients who reported significant medication-related adverse effects reported significantly greater activity interference, negative affect, and catastrophizing compared with those with fewer side effects ( < 0.01). In addition, those patients with pain who reported more side effects showed significantly higher scores on opioid misuse risk ( < 0.001).
This study demonstrates the important role of monitoring medication-related side effects among patients with chronic pain who are prescribed opioid medication for pain within primary care.
基层医疗从业者对使用阿片类药物治疗慢性疼痛(包括其不良反应)的担忧日益增加,但对于处方药副作用报告如何影响慢性疼痛患者的治疗结果却鲜有关注。本研究的目的是调查在基层医疗中,经常报告的副作用对服用阿片类药物的慢性疼痛患者的情绪、功能障碍和阿片类药物滥用的影响。
招募了200名服用阿片类药物治疗疼痛的慢性疼痛患者。所有患者均完成基线测量,并在6个月内每月填写一次副作用清单。根据6个月内认可的副作用数量的中位数将患者平均分组。研究结束时,受试者重复进行基线测量。
随着时间的推移,药物副作用报告趋于减少,但从基线到随访(6个月时间)报告的副作用频率差异不显著,报告的副作用频率顺序保持相似。与副作用较少的患者相比,报告有明显药物相关不良反应的患者报告的活动干扰、负面影响和灾难化思维显著更多(<0.01)。此外,报告副作用较多的疼痛患者在阿片类药物滥用风险方面得分显著更高(<0.001)。
本研究证明了在基层医疗中,对服用阿片类药物治疗疼痛的慢性疼痛患者监测药物相关副作用的重要作用。